coated tablet (Reference product)
Sponsors
International Bio Service Co., Ltd., International Bio Service Co. Ltd., International Bio Service Co., Ltd., International Bio Service Co.,Ltd
Conditions
Bioequivalence Study,Bioequivalence study,Healthy volunteers
Rosuvastatin, Bioequivalence Study, Healthy Thai Volunteerbioequivalence study,
Phase 1
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Tadalafil 20 mg Film-coated Tablets and Reference Product (CIALIS®) in Healthy Thai Male Volunteers under Fasting Condition
Active, not recruitingTCTR20170830001
Start: 2017-10-30Updated: 2026-03-30
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Etoricoxib 120 mg Film-coated Tablets and Reference Product (ARCOXIA, Frosst Iberica, S.A., Spain) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20180124005
Start: 2018-03-02Updated: 2026-03-30
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of MONTELUKAST TABLETS 10 mg and Reference Product (S1NGULAIR 10 mg (montelukast sodium, MSD)) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20180614001
Start: 2018-07-31Target: 40Updated: 2026-03-30
Bioequivalence Study of 20 mg Rosuvastatin Film-coated Tablets in Healthy Thai Volunteers
Active, not recruitingTCTR20180725005
Start: 2018-09-17Target: 32Updated: 2026-03-30
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Etoricoxib Tablets 120 mg and Reference Product (ARCOXIA 120 mg) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20180925005
Start: 2018-12-16Target: 28Updated: 2026-03-30